Precision BioSciences
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $0 | $10,838 | $34,204 | $13 |
Gross Profit | 10,838 | 34,204 | 13 | |
EBITDA | -32,099 | -17,490 | 20,274 | -20,736 |
EBIT | -32,352 | -18,130 | 19,596 | -21,410 |
Net Income | -32,652 | -18,441 | 20,133 | -21,772 |
Net Change In Cash | 0 | 10,838 | 34,204 | 13 |
Free Cash Flow | -13,522 | -11,955 | -11,284 | -15,270 |
Cash | 86,076 | 99,370 | 110,823 | 44,870 |
Basic Shares | 25,856 | 24,634 | 19,171 | 11,818 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $34,264 | $68,696 | $48,727 | $25,098 |
Gross Profit | 34,264 | 68,696 | 48,727 | 25,098 |
EBITDA | -42,434 | 13,526 | -32,042 | -62,794 |
EBIT | -45,187 | 8,949 | -40,297 | -71,798 |
Net Income | -45,724 | 7,167 | -61,319 | -111,637 |
Net Change In Cash | 34,264 | 68,696 | 48,727 | 25,098 |
Cost of Revenue | 45,913 | |||
Free Cash Flow | -65,928 | -58,695 | -86,392 | -49,072 |
Cash | 110,823 | 85,899 | 116,678 | 189,576 |
Basic Shares | 12,826 | 6,883 | 3,841 | 2,929 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.71 |
2026-03-31 | -$0.75 |
2025-12-31 | $1.00 |
2025-09-30 | -$1.84 |